MYELOMA VIIIth trial
Not Applicable
Completed
- Conditions
- CancerLeukaemiaeukaemia
- Registration Number
- ISRCTN52157196
- Lead Sponsor
- Medical Research Council (MRC) (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 1000
Inclusion Criteria
1. Greater than 65 years old and less than 75 years old
2. Myeloma
3. No previous cytotoxic therapy
4. Netrophil count greater than or equal to 1.3 x 10^9/l
5. Platelet count greater than or equal to 75 x 10^9/L
6. Able to tolerate 3 l of fluid per day
7. Apyrexial
8. Free from infection
9. Informed consent
Exclusion Criteria
Patients with equivocal myelomatosis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> 1. Survival<br> 2. Obtaining plateau (stable disease with no more than minimal symptoms)<br> 3. Quality of life<br>
- Secondary Outcome Measures
Name Time Method ot provided at time of registration